Exagen
XGN
34 hedge funds and large institutions have $44.7M invested in Exagen in 2020 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 4 closing their positions.
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
20% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 10
6% more funds holding
Funds holding: 32 → 34 (+2)
5.13% less ownership
Funds ownership: 33.68% → 28.55% (-5.1%)
34% less capital invested
Capital invested by funds: $67.8M → $44.7M (-$23.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$2.61M |
| 2 |
Goldman Sachs
New York
|
+$2.6M |
| 3 |
BlackRock
New York
|
+$955K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$479K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$463K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$9.17M |
| 2 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$4.04M |
| 3 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$1.07M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$1.01M |
| 5 |
Calamos Advisors
Naperville,
Illinois
|
-$924K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $27K | +$15.6K | +1,155 | +111% |
|
27
UBS Group
Zurich,
Switzerland
| $19K | -$5.62K | -415 | -22% |
|
28
Legal & General Group
London,
United Kingdom
| $10K | +$5.43K | +401 | +95% |
|
|
TRCT
29
Tower Research Capital (TRC)
New York
| $10K | +$10.8K | +798 | New |
|
30
Citigroup
New York
| $8K | -$4.46K | -330 | -34% |
|
|
PCM
31
Prelude Capital Management
New York
| $5K | – | – | – |
|
|
AIP
32
Ameritas Investment Partners
Lincoln,
Nebraska
| $4K | – | – | – |
|
|
CPA
33
Cowen Prime Advisors
New York
| $3K | +$6.77K | +500 | New |
|
|
NCGI
34
Next Century Growth Investors
Plymouth,
Minnesota
| – | -$4.04M | -253,288 | Closed |
|
|
MAG
35
Millrace Asset Group
Berwyn,
Pennsylvania
| – | -$1.07M | -67,235 | Closed |
|
|
MAM
36
Meeder Asset Management
Dublin,
Ohio
| – | -$21K | -1,351 | Closed |
|
|
SO
37
STRS Ohio
Columbus,
Ohio
| – | -$14K | -900 | Closed |
|
38
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$8.12K | -600 | -95% |
|
XGN Hedge Fund Activity: Q2 2020 in Review
34 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Exagen (XGN) for Q2 2020, worth a combined $44.7M — down 34% from $67.8M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new XGN positions and 4 closed out — a net gain of 3 holders — while 12 added to existing stakes and 10 trimmed.
The largest buyer was Cowen and Company, adding an estimated $2.61M. The largest seller was Victory Capital Management, cutting an estimated $9.17M.
- 34 institutional investors held Exagen (XGN) as of Q2 2020, up from 32 in Q1 2020.
- Funds reported $44.7M of Exagen stock for Q2 2020, down 34% quarter-over-quarter.
- 7 funds opened new Exagen positions in Q2 2020 and 4 closed out, a net change of +3 holders.
- The largest Exagen buyer in Q2 2020 was Cowen and Company, an estimated $2.61M added.
- The largest Exagen seller in Q2 2020 was Victory Capital Management, an estimated $9.17M sold.
Based on aggregated 13F filings for Q2 2020.